“…Most available computing processes and algorithms, such as principal component analysis or hierarchical clustering, enable the classifi cation of different tissues, e.g., healthy versus diseased, but fail to pinpoint discriminating m/z values that are needed for identifi cation of the corresponding biomolecules. Recently, nonimaging MALDI-TOF MS has been combined with linear discriminant analysis to achieve that goal ( 29 ). In microarray data sets even larger than MALDI images, Fisher discriminant analysis (FDA), a related discriminant analysis method, has successfully been applied for gene selection ( 30 ); it has previously been used for discrimination of magnetic resonance or positron emission tomography images (31)(32)(33).…”